Forbes January 13, 2024
Researchers have shown a single genetic test can be used alongside routine clinical data to find better cancer treatments.
In a landmark study of more than 13,000 patients in England, scientists discovered numerous ways sequencing a person’s genome could help tailor their care.
Almost all patients with brain tumours, and most with bowel or lung cancers, had DNA changes that might favour particular treatments over others.
Researchers also found valuable insights into sarcomas and ovarian cancer were also discovered during the study. Changes that could impact treatment decisions were spotted in about 10% of sarcomas, while the same proportion of ovarian cancers were shown to be likely inherited.
Whole genomic sequencing involves mapping all 3.2 billion letters that comprise a...
Today's Sponsors
Today's Sponsor